Peter Collignon
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance 28
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 42
- Pollution top 0.1%
- Pharmaceutical and Antibiotic Environmental Impacts 21
- Endocrinology top 0.2%
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 45
-
- Antimicrobial Resistance in Staphylococcus 47
-
- Infective Endocarditis Diagnosis and Management 29
- Pneumonia and Respiratory Infections 25
-
- Central Venous Catheters and Hemodialysis 19
- Co-authors
- Scott A. McEwenTania C. SorrellFrank M. AarestrupJohn TurnidgeJohn J. BeggsHenrik Caspar WegenerD. G. Joakim LarssonEdward Topp
- Journals
- The Medical Journal of Australia (46 papers)Clinical Infectious Diseases (9 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Peter Collignon
221 papers receiving 10.3k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Applied Microbiology and Biotechnology 1.7k
- Molecular Medicine 3.3k
- Pollution 2.9k
- Endocrinology 994
- Clinical Biochemistry 1.3k
Countries citing papers authored by Peter Collignon
This map shows the geographic impact of Peter Collignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Collignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Collignon more than expected).
Fields of papers citing papers by Peter Collignon
This network shows the impact of papers produced by Peter Collignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Collignon. The network helps show where Peter Collignon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Collignon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2020 | 31 | |
| 3 | 2018 | 6 | |
| 4 | 2018 | 246 | |
| 5 | 2017 | 14 | |
| 6 | 2017 | 24 | |
| 7 | 2016 | 2 | |
| 8 | 2016 | 232 | |
| 9 | 2012 | 45 | |
| 10 | 2012 | 17 | |
| 11 | 2011 | 95 | |
| 12 | 2010 | 1 | |
| 13 | 2009 | 283 | |
| 14 | 2009 | 8 | |
| 15 | 2006 | 83 | |
| 16 | 2002 | 1 | |
| 17 | 2000 | 200 | |
| 18 | 1997 | 15 | |
| 19 | Difficultés du diagnostic de la douleur chez l'enfant polyhandicapé | 1995 | 9 |
| 20 | 1983 | 74 |
About Peter Collignon
Peter Collignon is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 234 papers that have together received 10.7k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (47 papers), Bacterial Identification and Susceptibility Testing (45 papers), Antibiotic Resistance in Bacteria (42 papers), Infective Endocarditis Diagnosis and Management (29 papers), Antibiotic Use and Resistance (28 papers), Pneumonia and Respiratory Infections (25 papers), Pharmaceutical and Antibiotic Environmental Impacts (21 papers) and Central Venous Catheters and Hemodialysis (19 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.7k citations), Molecular Medicine (3.3k citations) and Pollution (2.9k citations). Peter Collignon has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Scott A. McEwen, Tania C. Sorrell, Frank M. Aarestrup, John Turnidge, John J. Beggs, Henrik Caspar Wegener, D. G. Joakim Larsson, Edward Topp, Awa Aïdara‐Kane and David W. Graham. Their work appears in journals such as The Medical Journal of Australia, Clinical Infectious Diseases, European Journal of Clinical Microbiology & Infectious Diseases, Emerging infectious diseases and Antimicrobial Resistance and Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.